Rebecsinib, an RNA Splicing and Base Editing Inhibitor to Target Cancer Stem Cells in Refractory Myeloid Malignancies
Grant Award Details
Grant Type:
Grant Number:
CLIN2-20409
Investigator(s):
Award Value:
$3,999,892
Status:
Pre-Active
Grant Application Details
Application Title: